Search Results - Ran Reshef
- Showing 1 - 16 results of 16
-
1
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report by Tyler Ruemmele, Rodney Macedo, Rodney Macedo, Mark N. Stein, Hei Ton Chan, Markus Y. Mapara, Markus Y. Mapara, Céline F. Jacquemont, Ran Reshef, Ran Reshef
Published in Frontiers in Oncology (2025-04-01)Get full text
Article -
2
-
3
682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoiet... by Yun Wang, Ran Reshef, Gavin MacBeath, Jim Murray, Debora Barton, Erica Buonomo, Shrikanta Chattopadhyay, Monzr Al Malki, Alla Keyzner, Hyung C Suh, Aasiya Matin, Nina Abelowitz
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
4
168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target by Ran Reshef, Charles Drake, Pawel Muranski, Emmanuel Antonarakis, Zoila (Areli) Lopez Bujanda, Aleksandar Obradovic, Thomas Nirschl, Timothy O’Donnell, Uri Laserson, Rodney Macedo-Gonzales, Tiezheng Yuan, Mithil Soni, Benjamin Larman
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
5
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial by Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Usama S. Gergis, Martin E. Guiterrez, Ran Reshef, Sumit K. Subudhi, Céline F. Jacquemont, Joseph H. Senesac, J. Henri Bayle, Charity D. Scripture, Monica S. Chatwal, Mehmet A. Bilen, Walter M. Stadler, Carlos R. Becerra
Published in Nature Communications (2024-12-01)Get full text
Article -
6
P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA by Ian W. Flinn, Caron Jacobson, Loretta J. Nastoupil, Franck Morschhauser, Andrew J. Davies, Christian Buske, Paolo Corradini, Armando Lopez-Guillermo, Ran Reshef, Vinod Parameswaran, Alison Sehgal, Michael Tees, Christine Lui, Wei Xue, Sara Beygi, Nikolay Grechko, Pisita Bolsue, Alessandro Giovanetti, Christina To, Myrna Nahas
Published in HemaSphere (2023-08-01)Get full text
Article -
7
TGM4: an immunogenic prostate-restricted antigen by Laura Crowley, Charles G Drake, Ran Reshef, Pawel Muranski, Aleksandar Obradovic, Timothy O’Donnell, Uri Laserson, Tiezheng Yuan, Emmanuel S Antonarakis, Zoila A Lopez-Bujanda, Thomas R Nirschl, Rodney Macedo, Alexandros Papachristodoulou, Jelani C Zarif, Mithil K Soni, Michael C Haffner, H Benjamin Larman, Michael M Shen
Published in Journal for ImmunoTherapy of Cancer (2021-06-01)Get full text
Article -
8
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide by Shannon R. McCurdy, Mei-Jie Zhang, Andrew St. Martin, Monzr M. Al Malki, Asad Bashey, Sameh Gaballa, Daniel A. Keesler, Mehdi Hamadani, Maxim Norkin, Miguel-Angel Perales, Ran Reshef, Vanderson Rocha, Rizwan Romee, Melhem Solh, Alvaro Urbano-Ispizua, Edmund K. Waller, Ephraim J. Fuchs, Mary Eapen
Published in Blood Advances (2018-02-01)Get full text
Article -
9
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treate... by Sarah Nikiforow, Tao Wang, Michael Hemmer, Stephen Spellman, Görgün Akpek, Joseph H. Antin, Sung Won Choi, Yoshihiro Inamoto, Hanna J. Khoury, Margaret MacMillan, David I. Marks, Ken Meehan, Hideki Nakasone, Taiga Nishihori, Richard Olsson, Sophie Paczesny, Donna Przepiorka, Vijay Reddy, Ran Reshef, Hélène Schoemans, Ned Waller, Daniel Weisdorf, Baldeep Wirk, Mary Horowitz, Amin Alousi, Daniel Couriel, Joseph Pidala, Mukta Arora, Corey Cutler
Published in Haematologica (2018-10-01)Get full text
Article -
10
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for Internat... by Aleksandr Lazaryan, Tao Wang, Stephen R. Spellman, Hai-Lin Wang, Joseph Pidala, Taiga Nishihori, Medhat Askar, Richard Olsson, Machteld Oudshoorn, Hisham Abdel-Azim, Agnes Yong, Manish Gandhi, Christopher Dandoy, Bipin Savani, Gregory Hale, Kristin Page, Menachem Bitan, Ran Reshef, William Drobyski, Steven GE Marsh, Kirk Schultz, Carlheinz R. Müller, Marcelo A. Fernandez-Viña, Michael R. Verneris, Mary M. Horowitz, Mukta Arora, Daniel J. Weisdorf, Stephanie J. Lee
Published in Haematologica (2016-10-01)Get full text
Article -
11
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak. by Monica Mehta, Lawrence J Purpura, Thomas H McConville, Matthew J Neidell, Michaela R Anderson, Elana J Bernstein, Donald E Dietz, Justin Laracy, Shauna H Gunaratne, Emily Happy Miller, Jennifer Cheng, Jason Zucker, Shivang S Shah, Shaoli Chaudhuri, Christian A Gordillo, Shreena R Patel, Tai Wei Guo, Lara E Karaaslan, Ran Reshef, Benjamin A Miko, Joan M Bathon, Marcus R Pereira, Anne-Catrin Uhlemann, Michael T Yin, Magdalena E Sobieszczyk
Published in PLoS ONE (2021-01-01)Get full text
Article -
12
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia by Evelyn H. Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Alexander Sanjurjo, Saagar Jain, Benjamin May, Demetra Tsapepas, Rebecca J. Leeman-Neill, Govind Bhagat, Geoffrey K. Dube, Heather Morris, Selim Arcasoy, Farhana Latif, Ersilia M. DeFilippis, Mercedes Martinez, Gene Y. Im, Meaghan M. Phipps, Marcus R. Pereira, Paul K. Sue, Manuela Orjuela-Grimm, Andrew H. Lipsky, Ahmed Sawas, Ran Reshef, Barbara Pro, Hua-Jay J. Cherng, Jennifer E. Amengual
Published in Blood Neoplasia (2025-11-01)Get full text
Article -
13
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703 by Sameem Abedin, Michael J. Martens, Javier Bolaños-Meade, Monzr M. Al Malki, Qinghua Lian, Lyndsey Runaas, Hany Elmariah, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Alison W. Loren, Melhem Solh, Amin M. Alousi, Omer H. Jamy, Miguel-Angel Perales, Andrew Rezvani, Ami Bhatt, Najla El Jurdi, Janny M. Yao, Kristy Applegate, Leslie S. Kean, Yvonne A. Efebera, Ran Reshef, William Clark, Eric Leifer, Wael Saber, Mary M. Horowitz, Richard J. Jones, Shernan G. Holtan, Mehdi Hamadani
Published in Blood Advances (2025-07-01)Get full text
Article -
14
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease by Hrishikesh K. Srinagesh, Umut Özbek, Urvi Kapoor, Francis Ayuk, Mina Aziz, Kaitlyn Ben-David, Hannah K. Choe, Zachariah DeFilipp, Aaron Etra, Stephan A. Grupp, Matthew J. Hartwell, Elizabeth O. Hexner, William J. Hogan, Alexander B. Karol, Stelios Kasikis, Carrie L. Kitko, Steven Kowalyk, Jung-Yi Lin, Hannah Major-Monfried, Stephan Mielke, Pietro Merli, George Morales, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Pavan Reddy, Ran Reshef, Wolf Rösler, Karamjeet S. Sandhu, Tal Schechter, Jay Shah, Keith Sigel, Daniela Weber, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, John E. Levine, James L.M. Ferrara
Published in Blood Advances (2019-12-01)Get full text
Article -
15
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma by Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Djordje Atanackovic, Shebli Atrash, Veronika Bachanova, Amer M. Beitinjaneh, Evguenia Bhurtel, Omar Castaneda Puglianini, Saurabh Chhabra, Kara I. Cicero, James A. Davis, Binod Dhakal, Danai Dima, Christopher J. Ferreri, Peter A. Forsberg, Ciara L. Freeman, Megan M. Herr, Tania Jain, Murali Janakiram, Jack Khouri, Mehmet H. Kocoglu, Anupama Kumar, Yuxin Liu, Frederick Locke, Joseph P. McGuirk, Lekha Mikkilineni, Omar Nadeem, Ricardo D. Parrondo, Oren Pasvolsky, Lauren C. Peres, Sneha Purvey, Shahzad Raza, Ran Reshef, Shambavi Richard, Adriana C. Rossi, Douglas W. Sborov, Leyla Shune, Charlotte B. Wagner, Saurabh S. Zanwar, Surbhi Sidana, Krina K. Patel, Doris K. Hansen, Shaji K. Kumar, Yi Lin, Thomas G. Martin, Peter M. Voorhees, Larry D. Anderson, Jr, Andrew J. Cowan, Gurbakhash Kaur
Published in Blood Advances (2025-05-01)Get full text
Article -
16
Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia by Noam E. Kopmar, Ted A. Gooley, Gregory W. Roloff, Amy Zhang, Ibrahim Aldoss, Chenyu Lin, Evandro Bezerra, Ibrahim Muhsen, Nikeshan Jeyakumar, Kaitlyn C. Dykes, Timothy O'Connor, Kevin Tang, Evan C. Chen, Matthew Connor, Noelle V. Frey, Christian A. Gordillo, Talal Hilal, Ali H. Al Darobi, Rasmus T. Hoeg, Vivian M. Irizarry Gatell, Yannis K. Valtis, Clayton W. Jackson, Vamsi K. Kota, Divya Koura, Jacob Boccucci, Caitlin Guzowski, Muthu V. Kumaran, Abdullah Ladha, Catherine J. Lee, Navneet S. Majhail, Shahbaz A. Malik, John Mathews, Katharine Miller, Jozal Moore, Luke Mountjoy, Kristen M. O'Dwyer, Silvina Odstrcil Bobillo, Caspian H. Oliai, Olalekan O. Oluwole, Roshini Pradeep, Tamer Othman, Aravind Ramakrishnan, Ran Reshef, Joshua Sasine, Sumithira Vasu, Marc Schwartz, Paul Shaughnessy, Maryann Stefan, Wendy Stock, Katherine C. Sutherland, Virginia Tan, Melhem M. Solh, Sean Tracy, Marlise Luskin, Aaron C. Logan, Jessica T. Leonard, LaQuisa Hill, Stephanie B. Tsai, Anjali S. Advani, Matthew Ulrickson, Veronika Bachanova, Bhagirathbhai Dholaria, Jae H. Park, Minoo Battiwalla, Rawan Faramand, Bijal D. Shah, George Yaghmour, Lori S. Muffly, Ryan D. Cassaday
Published in Blood Immunology & Cellular Therapy (2026-03-01)Get full text
Article
